Pioneering the new frontier of antibody cancer medicines

We are driven by a core purpose – to improve the lives of people with cancer. This is why we ensure that patients come first every step of the way as we harness the power of human antibodies to develop cancer therapeutics.

Approved Medicine

Tivdak® (Tisotumab Vedotin-tftv)

Learn more (For U.S. residents only)

  • Putting our expertise to work

    See how we put our in-depth knowledge of antibody biology into action

    Learn about our science

  • Innovation for the future

    Leveraging technologies to create first- or best-in-class products

    See our technologies

  • Partners in science

    See how our collaborative spirit drives our partnerships

    See current partners

You are now leaving to go to our collaborator’s website. If you continue, we encourage you to read the website’s privacy and cookie policy.